Aclaris Therapeutics Inc (NASDAQ:ACRS) had its Buy rating reiterated by Cantor Fitzgerald with a $50.00 price target

ME Staff
-
0

Analyst Ratings For Aclaris Therapeutics Inc (NASDAQ:ACRS)

Today, Cantor Fitzgerald reiterated its Buy rating on Aclaris Therapeutics Inc (NASDAQ:ACRS) with a price target of $50.00.

There are 3 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.

The current consensus rating on Aclaris Therapeutics Inc (NASDAQ:ACRS) is Buy with a consensus target price of $45.3333 per share, a potential 623.02% upside.

Some recent analyst ratings include

  • 3/22/2019-Aclaris Therapeutics Inc (NASDAQ:ACRS) had its Buy rating reiterated by Cantor Fitzgerald with a $50.00 price target
  • 2/8/2018-Aclaris Therapeutics Inc (NASDAQ:ACRS) has coverage initiated with a Buy ➝ Buy rating and $53.00 price target
  • 7/31/2017-Aclaris Therapeutics Inc (NASDAQ:ACRS) had its Buy rating reiterated by Jefferies Financial Group with a $36.00 price target
  • On 10/22/2018 Anand Mehra, Director, bought 372,093 with an average share price of $10.75 per share and the total transaction amounting to $3,999,999.75.
  • On 10/4/2018 Stephen A Tullman, Director, bought 7,100 with an average share price of $14.00 per share and the total transaction amounting to $99,400.00.
  • On 8/23/2018 Stephen A Tullman, Director, bought 6,600 with an average share price of $15.00 per share and the total transaction amounting to $99,000.00.
  • On 8/15/2018 Stephen A Tullman, Director, bought 6,250 with an average share price of $15.97 per share and the total transaction amounting to $99,812.50.
  • On 6/12/2018 Kamil Ali-Jackson, Insider, sold 5,000 with an average share price of $20.00 per share and the total transaction amounting to $100,000.00.
  • On 5/18/2018 Kamil Ali-Jackson, Insider, sold 10,000 with an average share price of $20.00 per share and the total transaction amounting to $200,000.00.
  • On 5/16/2018 Andrew Kenneth William Powell, Director, bought 500 with an average share price of $19.12 per share and the total transaction amounting to $9,560.00.

Recent Trading Activity for Aclaris Therapeutics Inc (NASDAQ:ACRS)
Shares of Aclaris Therapeutics Inc closed the previous trading session at 6,27 −0,16 2,49 % with 6.52 shares trading hands.